GLENMARK LIFE SCIENCES LIMITED IN

GLENMARK LIFE SCIENCES LIMITED Company Introduction:

Glenmark Life Sciences Limited is a leading developer and manufacturer of high-quality active pharmaceutical ingredients (APIs). The company focuses on chronic therapeutic areas including cardiovascular disease, central nervous system disorders, pain management, and anti-infectives. They also offer contract development and manufacturing services (CDMO) for APIs to global pharmaceutical companies. Glenmark Life Sciences is known for its strong R&D capabilities, robust quality systems, and state-of-the-art manufacturing facilities, serving customers in over 60 countries.

Classification:

Factory

GLENMARK LIFE SCIENCES LIMITED primarily manufactures and sells Active Pharmaceutical Ingredients (APIs) and provides Contract Development and Manufacturing Organization (CDMO) services to other pharmaceutical companies globally.

Their product portfolio (APIs) covers a wide range of therapeutic areas, including:

Cardiovascular System (CVS)

Central Nervous System (CNS)

Anti-infectives

Oncology (Anti-neoplastic)

Pain Management

Anti-diabetics

Respiratory System

Specific examples of Active Pharmaceutical Ingredients (APIs) they produce include:

Telmisartan

Olmesartan Medoxomil

Perindopril Erbumine

Atazanavir

Sacubitril

Tenofovir Disoproxil Fumarate

Dabigatran Etexilate

Rosuvastatin Calcium

Ezetimibe

Montelukast Sodium

Aripiprazole

Lurasidone Hydrochloride

Moxifloxacin Hydrochloride

Linezolid

Irinotecan Hydrochloride Trihydrate

Pemetrexed Disodium

Gemcitabine Hydrochloride

Capecitabine

Doxorubicin Hydrochloride

Oxaliplatin